DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Rogaine (for Men) is a drug marketed by Johnson And Johnson and is included in one NDA.
The generic ingredient in ROGAINE (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
A generic version of ROGAINE (FOR MEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.
Recent Clinical Trials for ROGAINE (FOR MEN)
Identify potential brand extensions & 505(b)(2) entrants
|University of Minnesota - Clinical and Translational Science Institute||Phase 2|
|The Skin of Color Society||Phase 4|
|Wake Forest University Health Sciences||Phase 4|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Johnson And Johnson||ROGAINE (FOR MEN)||minoxidil||SOLUTION;TOPICAL||019501-002||Feb 9, 1996||OTC||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|